![](/img/cover-not-exists.png)
Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: Comparison of T-cell and IL-2 activated killer (LAK) cell–mediated adoptive immunotherapy in murine models
Urania Vourka-Karussis, Aliza Ackerstein, Thea Pugatsch, Shimon SlavinVolume:
27
Year:
1999
Language:
english
Pages:
9
DOI:
10.1016/s0301-472x(98)00026-5
File:
PDF, 367 KB
english, 1999